Five healthcare stocks hit fresh 52-week lows as Sensex falls

The Sensex fell 242 points on Tuesday to close at 72,529. Amid the decline, five stocks from the BSE Healthcare Index touched fresh 52-week lows. Medico Remedies hit Rs 20.6 against a current price of Rs 22.15, down about 48% in a month. Pfizer marked Rs 3886.75 (down 16%), AstraZeneca Pharma India Rs 6217.5 (12%), Sanofi Consumer Healthcare India Rs 3815.25 (8%) and Eris Lifesciences Rs 1182.5 (7%).

Written by AI from Economic Times — Markets · not yet reviewed by an editor · Published 29 Sept 2026, 6:15 pm IST

Source

Economic Times — Markets · read the original report ↗

#stock market#healthcare stocks#52-week low#bse#sensex

Desk check · compared with the source

What the desk checked (4)

Sensex fell 242 points on Tuesday to close at 72,529. — Figure appears in source, attributed to ETMarkets.com report dated Sep 29, 2026; not independently verifiable here.
Five BSE Healthcare Index stocks touched fresh 52-week lows. — Stated in source and supported by the five named stocks listed with their low prices.
Medico Remedies hit a 52-week low of Rs 20.6 (CMP Rs 22.15) and fell about 48% in a month. — Figures appear in source; no exchange data source named beyond the publication.
Pfizer, AstraZeneca Pharma India, Sanofi Consumer Healthcare India and Eris Lifesciences declined about 16%, 12%, 8% and 7% respectively in a month. — All percentages and price levels are given in the source; internally consistent.

Written by AI from Economic Times — Markets · not yet reviewed by an editor · How we use AI · Report an error

Analysts’ view opinion

AI Economic Analyst

A 242-point Sensex dip is routine noise; five healthcare names simultaneously printing fresh 52-week lows is not. The pattern — multinational pharma arms like Pfizer, AstraZeneca Pharma India and Sanofi Consumer Healthcare India down 8-16% in a month, alongside domestic Eris Lifesciences at -7% and small-cap Medico Remedies at roughly -48% — points to sector-specific de-rating rather than a broad market rout. For investors this reads as money rotating out of a space that had been priced for defensive safety; for the companies themselves, nothing in this story says operations or earnings have changed.

The scale gap matters: the index fell well under half a percent while these stocks lost 7-48% in a month, so the selling is concentrated, not market-wide.
Medico Remedies' near-halving in a month is a small-cap liquidity story — thin volumes amplify moves in both directions and should not be read as the sector's trend.
Clustering of MNC pharma and consumer-healthcare names at lows suggests investors are repricing valuation and growth expectations in a segment often bought as a defensive hedge.
Who pays: existing shareholders and index-linked funds take the mark-to-market hit; who gains: value-oriented and long-horizon buyers, if earnings hold up.
Share-price weakness alone has limited read-through to jobs, output or drug prices — it raises the cost of equity capital, which bites only if firms need to raise funds.

What to watch — Watch whether these names stabilise or keep making lower lows into the next earnings season, and whether weakness spreads to the wider healthcare index rather than staying in these five.

The story establishes prices and percentage falls only — it offers no reason for the decline, no volume, valuation or earnings data, and no evidence of any business-level problem at these companies.

Deep dive

Research brief · 8 facts · 2 dates · exam-ready

The brief

Context

On Tuesday, September 29, 2026, India's benchmark BSE Sensex closed 242 points lower at 72,529. During the session, five constituents of the BSE Healthcare Index fell to fresh 52-week lows — their weakest traded prices in a year. A 52-week low is a widely watched technical marker of a stock's recent price performance, and clusters of such lows within one sector are read as a sign of sectoral weakness rather than a single-company problem.

Key facts

Sensex fell 242 points on Tuesday to close at 72,529 (report dated Sep 29, 2026, 05:51 PM IST).
Five stocks from the BSE Healthcare Index touched fresh 52-week lows in the session.
Medico Remedies hit a new 52-week low of Rs 20.6 against a current market price of Rs 22.15; down about 48% in the last month.
Pfizer hit a new 52-week low of Rs 3,886.75 against CMP Rs 3,924.85; down about 16% in the last month.
AstraZeneca Pharma India hit a new 52-week low of Rs 6,217.5 against CMP Rs 6,225; down about 12% in the last month.
Sanofi Consumer Healthcare India hit a new 52-week low of Rs 3,815.25 against CMP Rs 3,863.85; down about 8% in the last month.
Eris Lifesciences hit a new 52-week low of Rs 1,182.5 against CMP Rs 1,220.3; down about 7% in the last month.
Medico Remedies was the steepest one-month faller among the five, with a roughly 48% decline.

Timeline

Month preceding the reportThe five healthcare stocks decline between about 7% (Eris Lifesciences) and about 48% (Medico Remedies).
Tuesday, September 29, 2026Sensex closes down 242 points at 72,529; five BSE Healthcare Index stocks hit fresh 52-week lows.

Who has a stake

Retail and institutional investors in healthcare stocks — Mark-to-market losses; 52-week lows raise questions of whether to average down or exit.
Medico Remedies — Sharpest erosion among the five, about 48% in a month, with the stock at Rs 22.15 near its new low of Rs 20.6.
Multinational pharma arms listed in India (Pfizer, AstraZeneca Pharma India, Sanofi Consumer Healthcare India) — Valuations under pressure despite large-cap, high-priced scrips; weak price trend affects investor sentiment.
Eris Lifesciences — Domestic-focused pharma player at a new 52-week low of Rs 1,182.5 after a roughly 7% monthly fall.
BSE Healthcare Index — Sectoral index credibility as five constituents simultaneously print yearly lows, signalling broad-based weakness.

Why it matters

Healthcare is usually seen as a defensive sector that cushions portfolios when broader markets fall, so five index constituents hitting yearly lows on a day the Sensex slipped only 242 points suggests sector-specific stress beyond general market softness. For investors, clusters of 52-week lows are an early signal to re-examine sectoral allocation and valuations.

UPSC angle

Prelims pointers

Sensex closed at 72,529 on Tuesday, Sep 29, 2026, down 242 points.
52-week low: lowest price at which a stock traded in the preceding one year; used as a price-performance indicator.
BSE Healthcare Index is the sectoral index tracking healthcare and pharma stocks on the BSE.
Stocks at fresh 52-week lows: Medico Remedies (Rs 20.6), Pfizer (Rs 3,886.75), AstraZeneca Pharma India (Rs 6,217.5), Sanofi Consumer Healthcare India (Rs 3,815.25), Eris Lifesciences (Rs 1,182.5).
CMP (current market price) in each case was marginally above the new 52-week low, except Medico Remedies where the gap was wider.

Mains framing

A single-day 242-point fall in the Sensex to 72,529 need not by itself explain why five BSE Healthcare Index constituents printed fresh 52-week lows on the same day; the one-month declines of about 48% in Medico Remedies, 16% in Pfizer, 12% in AstraZeneca Pharma India, 8% in Sanofi Consumer Healthcare India and 7% in Eris Lifesciences point to sustained selling pressure within the sector rather than a one-session market dip. The spread of the fall across a small-cap formulations firm, three India-listed multinational pharma arms and a domestic branded-generics player indicates weakness is not confined to one business model or market-capitalisation band; the source does not state the reasons behind these declines. Analytically, such episodes test the conventional treatment of pharma and healthcare as a defensive hedge, and they underline the limits of the 52-week low as a valuation signal: it records price history, not earnings quality or business fundamentals. The way forward for investors is fundamentals-based scrutiny of order books, margins and regulatory exposure of individual companies, diversification across sectors, and caution against reading a yearly low either as automatic evidence of a bargain or of terminal decline.

Key terms

52-week low: The lowest price at which a stock has traded over the past one year, used as an indicator of recent price performance.
Sensex: The BSE's benchmark equity index; it closed at 72,529 after falling 242 points on the day reported.
BSE Healthcare Index: Sectoral index on the Bombay Stock Exchange tracking healthcare and pharmaceutical companies; five of its stocks hit yearly lows.
CMP (Current Market Price): The prevailing traded price of a stock, cited alongside each new 52-week low in the report.

Practice questions

Why are pharmaceutical and healthcare stocks conventionally treated as 'defensive' investments, and what does a cluster of 52-week lows in the BSE Healthcare Index reveal about the limits of that assumption?
Discuss the usefulness and limitations of technical markers such as the 52-week low for retail investors assessing whether a stock is undervalued.
Examine how movements in a benchmark index like the Sensex relate to, and diverge from, the performance of individual sectoral indices.

Grounded only in the source report — figures and dates are the source's, not inferred.

Next storyHeavy rain lashes northern Hyderabad; IMD issues orange alert →

← All stories